Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging roles of suppressor of cytokine signaling 3 in human cancers
Lirui Dai, Zian Li, Yiran Tao, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112262-112262
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Blue light photobiomodulation induced apoptosis by increasing ROS level and regulating SOCS3 and PTEN/PI3K/AKT pathway in osteosarcoma cells
Jiali Yang, Hui Jiang, Qiqi Fu, et al.
Journal of Photochemistry and Photobiology B Biology (2023) Vol. 249, pp. 112814-112814
Closed Access | Times Cited: 13
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality
Carlo Sorrentino, Luigi D’Antonio, Stefania L. Ciummo, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 19
PTK6 inhibits autophagy to promote uveal melanoma tumorigenesis by binding to SOCS3 and regulating mTOR phosphorylation
Bo Liu, Xueting Yao, Chaoyang Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
Martina Morelli, Stefania Madonna, Cristina Albanesi
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response
Abdollah Jafarzadeh, Zahra Jafarzadeh, Maryam Nemati, et al.
Helicobacter (2024) Vol. 29, Iss. 3
Closed Access | Times Cited: 4
Association of Selected STAT Inhibitors with Prolactin-Induced Protein (PIP) in Breast Cancer
Karolina Jabłońska, Alicja Kmiecik, Katarzyna Nowińska, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1416-1416
Open Access
PLGA-based biocompatible nanoparticles improved anti-breast tumor efficacy of 1,25(OH)2D3 through the SOCS3/STAT3/EMT signaling axis
Jinjing Pan, Ping Wang, Ling‐Hong Xiong, et al.
Journal of Functional Foods (2025) Vol. 126, pp. 106700-106700
Open Access
Cancer cell-derived exosomal miR-34a inhibits the malignant progression of pancreatic adenocarcinoma cells by restraining the M2 polarization of macrophages
Kui Long, Kui Xiang, Qingbin Zeng, et al.
European Journal of Histochemistry (2025) Vol. 69, Iss. 2
Open Access
Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer
Yan Yao, Xinru Kong, Ruijuan Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway
Sivan Izraely, Shlomit Ben‐Menachem, Sapir Malka, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1513-1513
Open Access | Times Cited: 9
PEGylated SOCS3 Mimetics Encapsulated into PLGA-NPs as Selective Inhibitors of JAK/STAT Pathway in TNBC Cells
Sara La Manna, Alessia Cugudda, Flavia Anna Mercurio, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7237-7251
Open Access | Times Cited: 3
Sirtuin 6 maintains epithelial STAT6 activity to support intestinal tuft cell development and type 2 immunity
Xiwen Xiong, Chenyan Yang, Wei He, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Theranostic Potential of EFNB2 for Cetuximab Resistance in Head and Neck Cancer
Raushan Kumar Chaudhary, Prakash Patil, Uday Venkat Mateti, et al.
Indian Journal of Otolaryngology and Head & Neck Surgery (2023) Vol. 75, Iss. 3, pp. 1923-1936
Closed Access | Times Cited: 7
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer
Lirui Dai, Yiran Tao, Zimin Shi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
A zebrafish HCT116 xenograft model to predict anandamide outcomes on colorectal cancer
Francesca Maradonna, Camilla Maria Fontana, Fiorenza Sella, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 12
Open Access | Times Cited: 11
SOCS3 acts as a potential negative regulator in the antiviral response of large yellow croaker (Larimichthys crocea) by interacting with STAT1
You Chen, Huazhi Chen, Shuaiwei Ren, et al.
Water Biology and Security (2024) Vol. 3, Iss. 3, pp. 100270-100270
Open Access | Times Cited: 2
Dysregulated expression of the suppressors of cytokine signaling (SOCS) contributes to the development of prostate cancer
Abdollah Jafarzadeh, Raziyeh Zandvakili, Zahra Jafarzadeh, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155558-155558
Closed Access | Times Cited: 2
Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma
Lirui Dai, Yongjie Han, Zhuo Yang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 15, pp. 2194-2214
Open Access | Times Cited: 6
SOCS proteins and their roles in the development of glioblastoma (Review)
Lirui Dai, Zian Li, Wulong Liang, et al.
Oncology Letters (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 14
MicroRNAs Regulate Tumorigenesis by Downregulating SOCS3 Expression: An In silico Approach
Sura Ali Al-Asadi, Hiba Mansour, Ahmed Jwaid Ataimish, et al.
Bioinformatics and Biology Insights (2023) Vol. 17
Open Access | Times Cited: 5
Tumor Cell-Derived Exosomal miR-191-5p Activates M2-Subtype Macrophages Through SOCS3 to Facilitate Breast Cancer
Jun Ni, Xun Xi, Sujian Xiao, et al.
Molecular Biotechnology (2024) Vol. 66, Iss. 5, pp. 1314-1325
Closed Access | Times Cited: 1
5-AZA Upregulates SOCS3 and PTPN6/SHP1, Inhibiting STAT3 and Potentiating the Effects of AG490 against Primary Effusion Lymphoma Cells
Michele Di Crosta, Andrea Arena, Rossella Benedetti, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 3, pp. 2468-2479
Open Access | Times Cited: 1
The role of interleukin‐6 family cytokines in cancer cachexia
Samet Agca, Serkan Kır
FEBS Journal (2024)
Open Access | Times Cited: 1
A cancer-associated fibroblasts related risk score (CAFscore) helps to guide prognosis and personal treatment for Glioblastoma
Hongyu Li, Qinjian Liu, Guoyin Li, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Inhibitory DNA Aptamer Tools against SOCS3-gp130 Interactions
Xinna Zhang, Yu Hou, Weichang Chen, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top